ReviewDrug design, development and therapy2018

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives.

Francesco Facchinetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.